If Virtual Health Care Is the Future, Then This TSX Stock Is a Screaming Buy

Here’s why I think Dialogue Health (TSX:CARE) is an intriguing growth option for investors to consider right now.

| More on:
healthcare pharma

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

The telemedicine sector is red hot right now. Indeed, the innovation this sector provides has been necessary as a result of the pandemic.

However, for those banking on the long term, this sector could be a great one to invest in right now. Pandemic-friendly stocks are selling off right now. For those who believe in a telemedicine-oriented future, now’s the time to buy.

One of the newer entrants onto the TSX, Dialogue Health (TSX:CARE) is an intriguing option in this space. Here’s more on what this company does and why I think it’s an interesting pick today.

High demand driving growth

The pandemic resulted in a surge in patient demand for telemedicine solutions. Many doctors’ offices simply wouldn’t let patients come in for various reasons. Being able to treat non-acute medical issues via a virtual modality is something that has become second nature to many healthcare providers and patients of late.

It wasn’t always this way. The healthcare sector is one that hasn’t changed much over the past century. It’s a sector that’s traditionally been difficult to innovate in. Companies like Dialogue Health are re-shaping this argument.

Surging demand and regulatory requirements combined to provide the perfect tailwind for Dialogue to go public. Since going public, this stock has waned, trading nearly 40% below its all-time high. This comes despite rather bullish numbers released by the company of late.

Dialogue’s virtual platform features a lucid user interface and a well-organized architecture. These have been instrumental in expanding this company’s large customer base. This is a 24/7 multi service hub with more than 2,000 direct customers and 50,000 customers via its various partnerships. Dialogue links individuals with over 500 multifaceted healthcare providers across a number of clinical specialties in primary and mental health care.

Analysts are bullish on Dialogue 

After Dialogue became listed on the TSX on March 30, David Newman, an analyst at Desjardins Securities, initiated coverage of the company. He’s bullish on this stock owing to different factors, which he pointed out in his recent research report.

These include Dialogue’s excellent position in the virtual care space, and the company’s focus on the B2B market, which is currently poised for disruption. This company has an ideal business model, which has ensured a high customer-retention rate. Moreover, Dialogue has displayed strong revenue generation consistently.

Furthermore, Dialogue’s advanced platform is one that’s highly scalable. With an efficient management team steering the ship, many expect this company to produce some impressive growth long-term. This growth could potentially be supplemented by additional M&A activity over the medium term.

Bottom line

Undoubtedly, there appears to be a tonne of upside for Dialogue, as it continues to implement its effective strategy to build its one-of-a-kind Integrated Health Platform. It certainly has the potential to grow its operations and extend its offering to new locations via strategic acquisitions.

I believe that Dialogue is well positioned to disrupt a sector that many believed as impossible to penetrate. Accordingly, this company represents the innovation of the future.

Indeed, that’s something every long-term investor can get behind.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Investing

Man holding magnifying glass over a document

3 Heavily Shorted TSX Stocks to Watch This Summer

Canadians should monitor heavily shorted TSX stocks like Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) in this bear market.

Read more »

Airport and plane

3 TSX Stocks Set to Take Off With Summer Travel

Canadians should direct their attention to the travel industry and snatch up TSX stocks like Air Canada (TSX:AC) and others…

Read more »


Young Investors: 3 Canadian Stocks You Can Trust as Inflation Rises

Inflation has soared to new heights, which should spur young investors to snatch up Canadian stocks like Empire Company Ltd.…

Read more »

analyze data

2 Tech Stocks That Benefit From the Decline of Crypto

Crypto's bear market creates opportunities for traditional rivals like Lightspeed (TSX:LSPD)(NYSE:LSPD).

Read more »

Growing plant shoots on coins

Why This Canadian Growth Stock Could Double Next Thursday

This growth stock is set to soar if market recovery continues and what analysts expect from the company continues.

Read more »

Glass piggy bank

Market Correction: Boost Your Retirement Fund With These 2 Stocks

The correction in top TSX stocks presents a solid opportunity for investors with long-term financial goals to buy shares of…

Read more »

Happy family father of mother and child daughter launch a kite on nature at sunset
Dividend Stocks

Parents: Here’s Every Credit and Benefit You Can Claim From the CRA

Parents have it hard already, so make sure the CRA is doing everything for you by dishing out payments you're…

Read more »

edit Colleagues chat over ketchup chips
Dividend Stocks

3 Canadian Dividend Stocks to Buy and Hold for Life

These dividend-paying stocks have solid earnings base to support their payouts for decades.

Read more »